Insider Selling: CAMP4 Therapeutics (NASDAQ:CAMP) Director Sells $144,081.00 in Stock

CAMP4 Therapeutics Corporation (NASDAQ:CAMP) Director Andrew Schwab sold 32,018 shares of the stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $4.50, for a total transaction of $144,081.00. Following the transaction, the director owned 2,433,280 shares of the company’s stock, valued at approximately $10,949,760. This represents a 1.30% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

CAMP4 Therapeutics Trading Up 0.4%

CAMP stock traded up $0.02 during mid-day trading on Friday, reaching $4.48. The company’s stock had a trading volume of 126,663 shares, compared to its average volume of 183,971. The company has a market cap of $281.12 million, a price-to-earnings ratio of -1.93 and a beta of 0.22. CAMP4 Therapeutics Corporation has a 12 month low of $1.41 and a 12 month high of $7.75. The business’s 50 day moving average price is $4.11 and its 200 day moving average price is $4.33.

CAMP4 Therapeutics (NASDAQ:CAMP) last released its earnings results on Thursday, August 13th. The Wireless communications provider reported ($0.58) EPS for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.34). CAMP4 Therapeutics had a negative net margin of 2,543.74% and a negative return on equity of 252.79%. The business had revenue of $1.78 million for the quarter. As a group, equities analysts expect that CAMP4 Therapeutics Corporation will post -0.59 EPS for the current fiscal year.

Hedge Funds Weigh In On CAMP4 Therapeutics

Several hedge funds have recently modified their holdings of CAMP. China Universal Asset Management Co. Ltd. acquired a new position in CAMP4 Therapeutics during the fourth quarter valued at $61,000. Jefferies Financial Group Inc. acquired a new position in CAMP4 Therapeutics during the fourth quarter worth $70,000. State Street Corp lifted its holdings in CAMP4 Therapeutics by 52.7% during the 4th quarter. State Street Corp now owns 39,700 shares of the Wireless communications provider’s stock worth $243,000 after purchasing an additional 13,700 shares in the last quarter. Bank of America Corp DE bought a new position in shares of CAMP4 Therapeutics during the fourth quarter valued at approximately $86,000. Finally, OMERS ADMINISTRATION Corp bought a new stake in CAMP4 Therapeutics in the 4th quarter worth approximately $115,000.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the stock. JPMorgan Chase & Co. upgraded shares of CAMP4 Therapeutics from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $5.00 to $9.00 in a research report on Tuesday, June 16th. UBS Group set a $15.00 price target on shares of CAMP4 Therapeutics in a research note on Friday, August 14th. Piper Sandler reissued an “overweight” rating and issued a $15.00 price target (up from $12.00) on shares of CAMP4 Therapeutics in a report on Friday, August 14th. Weiss Ratings raised shares of CAMP4 Therapeutics from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, August 14th. Finally, Chardan Capital set a $6.50 price target on shares of CAMP4 Therapeutics and gave the company a “buy” rating in a research report on Wednesday, June 10th. Seven equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, CAMP4 Therapeutics currently has an average rating of “Moderate Buy” and an average target price of $9.56.

About CAMP4 Therapeutics

CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company operates in two segments, Software & Subscription Services and Telematics Products. It provides CalAmp Telematics Cloud platform, such as cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open application programming interfaces; and software as a service application, as well as provides tracking and monitoring services within fleet management, supply chain integrity, and international vehicle location.